Career Opportunities with Health Canada

Date/Time

Date - 23/09/2020
6:00 pm - 7:00 pm

Career Opportunities with Health Canada

Register NOW and join us for the first LSCDS Career Seminar Series event of the new academic year!

This seminar is designed to introduce you to career opportunities with Health Canada, covering the following topics:

  • Health Canada: What we do
  • Organizational structure of Health Canada
  • General process for drug authorization
  • Jobs at Health Canada
  • General requirements for a scientific/clinical evaluator

Date: Wednesday, September 23th, 2020
Time: 6:00 pm – 7:00 pm
Location: Zoom (the link will be distributed upon registration)

Register for the Event

Speakers

Yannan (Nancy) Dou, PhD

Senior Clinical Evaluator, Clinical Evaluation Division – Radiopharmaceuticals and Haematology in Centre for Evaluation of Radiopharmaceuticals & Biotherapeutics (CERB), Biologic and Radiopharmaceutical Drugs Directorate (BRDD), Health Canada

Nancy works as a senior clinical evaluator in the Clinical Evaluation Division – Radiopharmaceuticals/Haematology (CED-RH) under the Biologic and Radiopharmaceutical Drugs Directorate (BRDD). She joined Health Canada in 2018 and has been a part of both the pre-market authorization and the clinical trial divisions. She has extensive experience in the review of biologics, radiopharmaceutics, prescription drugs, biosimilars, and generic drugs. Nancy obtained her PhD degree from the Leslie Dan Faculty of Pharmacy at the University of Toronto, where she published a number of journal articles on drug formulation development and translational research.

Nancy is also a proud mom of two lovely boys and enjoys cooking during her spare time.

Jian Wang, MD, PhD

Division Manager, Clinical Evaluation Division – Radiopharmaceuticals and Haematology in Centre for Evaluation of Radiopharmaceuticals & Biotherapeutics (CERB), Biologic and Radiopharmaceutical Drugs Directorate (BRDD), Health Canada

Dr. Jian Wang is the Division Manager of Clinical Evaluation Division – Radiopharmaceuticals/Haematology (CED-RH). He manages a team of scientific, clinical and medical evaluators responsible for pre-market assessment of scientific and clinical data. His division has regulatory responsibility for assessing non-clinical, pharmacology and clinical data for biological drugs, including gene therapies and biosimilars, for the treatment of haematological, oncological, and infectious diseases. The Division also regulates radiopharmaceuticals (for all indications). Dr. Wang has broad regulatory experience in pre-market drug regulations for generics, biologics, biosimilars and radiopharmaceuticals. He joined the Health Canada Pesticide Management Regulatory Agency in 1996. He started working for the Therapeutic Products Directorate (TPD) in early 1999. Then in 2001, Dr. Wang moved to BRDD. He actively participates in various Health Canada, ICH, WHO and DIA working groups and expert committees.

Dr. Wang has received his medical degree in China and his PhD from the University of British Columbia in Canada.

Register for the Event

Sponsors